Bruno Sangro
Hepatologist at Clínica Universidad de Navarra and a leading international investigator in liver cancer systemic therapy and radioembolisation.
Overview
Bruno Sangro leads translational research on the Executive Committee of the Cancer Center Clínica Universidad de Navarra and directs the Liver Unit at the clinic. He has been a principal investigator in major hepatocellular carcinoma trials, including immunotherapy combinations, and has contributed to EASL and ESMO guidelines for liver cancer.
Pages like this
not linked directly; found by shared links- PersonJia Fan
Shares Biliary tract cancer (cholangiocarcinoma), Hepatocellular carcinoma and the tags clinician-scientist, liver cancer.
- PersonJosep Maria Llovet
Shares Hepatocellular carcinoma and the tags clinician-scientist, liver cancer.
- PersonIgnacio Melero
Shares Cancer Center Clínica Universidad de Navarra / CIMA, Hepatocellular carcinoma and the tag immunotherapy.
- PersonLars Zender
Shares Hepatocellular carcinoma and the tags clinician-scientist, liver cancer.
- PersonKenneth K. Tanabe
Shares Hepatocellular carcinoma and the tags clinician-scientist, liver cancer.
- PersonJesús San Miguel
Shares Cancer Center Clínica Universidad de Navarra / CIMA and the tag clinician-scientist.
- CompanyTyra Biosciences
Shares Biliary tract cancer (cholangiocarcinoma), Hepatocellular carcinoma.
- PersonAntonio Rosato
Shares the tags clinician-scientist, immunotherapy.